Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Single-Dose Study of Tivozanib in Subjects With Hepatic Impairment and Normal Hepatic Function

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01631097
Recruitment Status : Completed
First Posted : June 28, 2012
Last Update Posted : January 27, 2014
Sponsor:
Information provided by (Responsible Party):
AVEO Pharmaceuticals, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : January 2014
Actual Study Completion Date : January 2014